The store will not work correctly when cookies are disabled.
1-(2,3,5,6,7,8-hexahydroisoquinolin-3-yl)guanidine
ID: ALA4764564
PubChem CID: 162660810
Max Phase: Preclinical
Molecular Formula: C10H16N4
Molecular Weight: 192.27
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: N=C(N)NC1C=C2CCCCC2=CN1
Standard InChI: InChI=1S/C10H16N4/c11-10(12)14-9-5-7-3-1-2-4-8(7)6-13-9/h5-6,9,13H,1-4H2,(H4,11,12,14)
Standard InChI Key: CDQCFGYTKJPHKT-UHFFFAOYSA-N
Molfile:
RDKit 2D
14 15 0 0 0 0 0 0 0 0999 V2000
14.8752 -7.4831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5847 -7.0609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7317 -7.4655 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5776 -6.2330 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.2998 -7.4698 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8611 -5.8275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0161 -7.0550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0128 -6.2265 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1542 -7.0731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1505 -6.2460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4364 -5.8379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7213 -6.2523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7250 -7.0794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4437 -7.4920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9 1 2 0
6 10 2 0
7 8 2 0
5 7 1 0
2 5 1 0
4 6 1 0
7 3 1 0
2 1 1 0
2 4 1 0
9 10 1 0
9 14 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 192.27 | Molecular Weight (Monoisotopic): 192.1375 | AlogP: 0.78 | #Rotatable Bonds: 1 |
Polar Surface Area: 73.93 | Molecular Species: BASE | HBA: 2 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 11.57 | CX LogP: 0.57 | CX LogD: -1.84 |
Aromatic Rings: ┄ | Heavy Atoms: 14 | QED Weighted: 0.37 | Np Likeness Score: 0.48 |
References
1. McMullan M,Kelly B,Mihigo HB,Keogh AP,Rodriguez F,Brocos-Mosquera I,García-Bea A,Miranda-Azpiazu P,Callado LF,Rozas I. (2021) Di-aryl guanidinium derivatives: Towards improved α2-Adrenergic affinity and antagonist activity., 209 [PMID:33139112] [10.1016/j.ejmech.2020.112947] |